« Previous
Next »
Titles
- Tackling America's mental health and addiction crisis through primary care integration1
- Taking a teen pregnancy prevention program to the home: the AIM 4 Teen Moms experience1
- Tale of two states: transforming child care in New Mexico and Alabama1
- Tax administration: IRS oversight of hospitals’ tax-exempt status : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives1
- Technical assistance brief: implementation of inflation-indexed rebates for Part B drugs1
- Technical considerations for additive manufactured medical devices: guidance for industry and Food and Drug Administration staff1
- Technical considerations for medical devices with physiologic closed-loop control technology: guidance for industry and Food and Drug Administration staff1
- Technical considerations for non-clinical assessment of medical devices containing nitinol: guidance for industry and Food and Drug Administration staff1
- Technical performance assessment of quantitative imaging in radiological device premarket submissions: guidance for industry and Food and Drug Administration staff1
- Technical specifications for submitting clinical trial data sets for treatment of noncirrhotic nonalcoholic steatohepatitis (NASH)2
- Technology assessment: Vaccine development : capabilities and challenges for addressing infectious diseases : report to congressional committees1
- Teen pregnancy prevention programs for American Indian and Alaska Native youth1
- Telehealth was critical for providing services to Medicare beneficiaries during the first year of the COVID-19 pandemic1
- Telehealth: use in Medicare and Medicaid : testimony before the Subcommittee on Agriculture, Energy, and Trade and Subcommittee on Health and Technology, Committee on Small Business, House of Representatives1
- Telepharmacy rules and statutes: a 3-year update for all 50 states1
- Temporary policy for compounding of certain drugs for hospitalized patients by outsourcing facilities during the COVID-19 public health emergency (revised)1
- Temporary policy for compounding of certain drugs for hospitalized patients by pharmacy compounders not registered as outsourcing facilities during the COVID-19 public health emergency (revised)1
- Temporary policy for manufacture of alcohol for incorporation into alcohol-based hand sanitizer products during the public health emergency (COVID-19)1
- Temporary policy for preparation of certain alcohol-based hand sanitizer products during the public health emergency (COVID-19)2
- Temporary policy on Prescription Drug Marketing Act requirements for distribution of drug samples during the COVID-19 public health emergency1